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In the preparation of this article, we made two typographical errors that we wish to correct:
(1) The right promoter (marked by the right red box) in Figure 3B is incorrectly labeled. The correct label is: ‘‘Annotated islet-active
promoter.’’
(2) The second sentence of the third paragraph in the Discussion section is incorrect. The corrected sentence is: ‘‘Focusing on
T2D, 4 of the 12 elements that function as enhancers in vitro (FTO, KCNQ1, TCF7L2, andWFS1 loci) harbor T2D-associated
SNPs, including two (TCF7L2 and WFS1 loci) that exhibit significant allele-specific differences in activity.This correction does not affect the data or the conclusions of the paper, and we apologize for any confusion the errors may have
caused.Cell Metabolism 12, 683, December 1, 2010 ª2010 Elsevier Inc. 683
